Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease

Hypertension and proteinuria are well-known predictors of chronic kidney disease (CKD) progression. Therapeutic interventions have different magnitude of albuminuria and hypertension. This study was designed to evaluate the efficacy and safety of combined vs. single renin-angiotensin-aldosterone sys...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Medicine Science
المؤلفون الرئيسيون:	Mona A. Abdelrahman, Ashraf Genina, Amira S. A. Said, Mohamed E. A. Abdelrahim
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Society of Turaz Bilim 2016-09-01
الموضوعات:	Renin-angiotensin-aldosterone system proteinuria chronic kidney disease (CKD) Angiotensin converting enzyme inhibitor (ACEI) angiotensin receptor blocker (ARB) dual therapy renal failure hypertension diabetic nephropathy and dual RAAS blockade combination
الوصول للمادة أونلاين:	http://www.ejmanager.com/fulltextpdf.php?mno=211993

مواد مشابهة

Atrial fibrillation in heart failure patients: An update on renin–angiotensin–aldosterone system pathway blockade as a therapeutic and prevention target
حسب: Ioanna Koniari, وآخرون
منشور في: (2023-04-01)

Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
حسب: Yan-Huan Feng, وآخرون
منشور في: (2016-01-01)

Activation of the renin-angiotensin-aldosterone system in mares around ovulation
حسب: Katy Satué, وآخرون
منشور في: (2017-06-01)

Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations
حسب: Gallo G, وآخرون
منشور في: (2022-07-01)

Drugs acting on the renin–angiotensin–aldosterone system (RAAS) and deaths of COVID-19 patients: a systematic review and meta-analysis of observational studies
حسب: Ruchika Sharma, وآخرون
منشور في: (2022-09-01)

The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation
حسب: Agnese Valentini, وآخرون
منشور في: (2025-08-01)

The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis
حسب: Heleniak Zbigniew, وآخرون
منشور في: (2016-12-01)

Controversy over renin–angiotensin–aldosterone system (RAAS) inhibitors treatment in nephrology and cardiovascular diseases
حسب: Rafał Ł. Donderski, وآخرون
منشور في: (2020-06-01)

The dual blockade of the renin-angiotensin system in Internal Medicine: after ONTARGET trial
حسب: F. Rondoni, وآخرون
منشور في: (2013-05-01)

The evolutionary development of the renin angiotensin aldosterone system and its importance for the survival of the human species
حسب: Natalia Butt-Hussaim, وآخرون
منشور في: (2021-03-01)

Assessment of Parathyroid Hormone, Vitamin D, Calcium, and Renin-angiotensin-aldosterone System in Nigerians With Hypertension
حسب: Oloruntoba Ayodele Ekun, وآخرون
منشور في: (2024-08-01)

Assessment of Oxidative Stress Markers in Hypertensive Patients under the Use of Renin-Angiotensin-Aldosterone Blockers
حسب: Nestor Vazquez-Agra, وآخرون
منشور في: (2023-03-01)

Renal denervation inhibits the renin–angiotensin–aldosterone system in spontaneously hypertensive rats
حسب: Fei Qin, وآخرون
منشور في: (2022-01-01)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
حسب: Ming-Hui Zheng, وآخرون
منشور في: (2020-08-01)

Duration of rheumatoid arthritis changes blood levels of angiotensin and aldosterone
حسب: Boris A. Rebrov, وآخرون
منشور في: (2023-12-01)

Beyond the circulating renin angiotensin aldosterone system
حسب: Walmor eDe Mello
منشور في: (2014-07-01)

Canagliflozin on top of dual renin-angiotensin system blockade in a woman with partial acquired lipodystrophy, type 2 diabetes and severely proteinuric chronic kidney disease: a case report
حسب: Edoardo Biancalana, وآخرون
منشور في: (2023-05-01)

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
حسب: Matthew Miller, وآخرون
منشور في: (2022-09-01)

The renin angiotensin aldosterone system and COVID-19
حسب: Hadeel A. Alsufyani, وآخرون
منشور في: (2020-08-01)

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers impact on the gut microbiome: a systematic review
حسب: Elisabeth M. Wang, وآخرون
منشور في: (2025-10-01)

Advances in Unraveling the Role of the Renin-Angiotensin-AldosteroneSystem in Osteoporosis Pathogenesis
حسب: Zige Liu, وآخرون
منشور في: (2024-01-01)

Treatment of hypertension during the COVID-19 pandemic: questions about the blockade of the renin-angiotensin-aldosterone system
حسب: S. G. Kanorskiy
منشور في: (2021-04-01)

Patiromer to Reduce Albuminuria Through Increased Renin Angiotensin Aldosterone System Inhibition in Patients With CKD-A Feasibility Trial
حسب: Frederik H. Mårup, وآخرون
منشور في: (2024-08-01)

Efficacy of Shenkang Injection combined with renin-angiotensin-aldosterone system blockers in diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials
حسب: Xinyue Zhang, وآخرون
منشور في: (2025-12-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes: the role of renin-angiotensin-aldosterone system (literature review) (part 2)
حسب: K. V. Skobeleva, وآخرون
منشور في: (2021-06-01)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
حسب: Kazuyuki Hirooka, وآخرون
منشور في: (2022-03-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes mellitus: the role of renin-angiotensin-aldosterone system (literature review) (part 1)
حسب: K. V. Skobeleva, وآخرون
منشور في: (2021-06-01)

The effect of renin-angiotensin system blockers on aldosterone levels in patients with chronic heart failure with preserved ejection fraction
حسب: A. N. Shevelok
منشور في: (2020-12-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
حسب: Shuichi Ichikawa, وآخرون
منشور في: (2011-06-01)

Therapeutic Implications of Renin–Angiotensin System Modulators in Alzheimer’s Dementia
حسب: Daniela-Carmen Ababei, وآخرون
منشور في: (2023-09-01)

Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension – study protocol for a randomized controlled trial
حسب: Elizabeth do Espirito Santo Cestário, وآخرون
منشور في: (2018-02-01)

Proteinuria: pathophysiology, diagnostic and therapeutic approach
حسب: Enrico Valvo
منشور في: (2013-04-01)

Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
حسب: Jordan Loader, وآخرون
منشور في: (2022-06-01)

Effects of Interactions among Gene Polymorphisms of the Renin–Angiotensin-Aldosterone System on Hypertension in Turkish People from Southeast Anatolia
حسب: Arpacı Abdullah, وآخرون
منشور في: (2019-04-01)

The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19
حسب: M. Ekholm, وآخرون
منشور في: (2021-06-01)

RAAS inhibitors are associated with a better chance of surviving of inpatients with Covid-19 without a diagnosis of diabetes mellitus, compared with similar patients who did not require antihypertensive therapy or were treated with other antihypertensives
حسب: Mykola Khalangot, وآخرون
منشور في: (2023-01-01)

Limited evidence for the usage of renin–angiotensin–aldosterone pathway blockers to prevent arthrofibrosis after total knee arthroplasty. A systematic review of clinical evidence
حسب: Giuseppe Anzillotti, وآخرون
منشور في: (2024-10-01)

Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia
حسب: Xinwu Huang, وآخرون
منشور في: (2017-06-01)

Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment
حسب: Jose L. Labandeira-Garcia, وآخرون
منشور في: (2022-02-01)

Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement
حسب: Fabrizio Buffolo, وآخرون
منشور في: (2021-05-01)